| CARIS LIFE SCIENCES |
| USA |
| Gesundheit |
| US1421521071 / A41A14 |
| 49J (Frankfurt) / CAI (NASDAQ) |
| FRA:49J, ETR:49J, 49J:GR, NASDAQ:CAI |
| - |
| https://www.carislifescie.. |
|
Caris Life Sciences is a leading AI-driven precision medicine company that transforms healthcare through comprehensive molecular profiling and advanced machine learning. The company specializes in analyzing cancer at the molecular level by performing..
>Volltext.. |
| 4683.08 Mio. EUR |
| 4366.15 Mio. EUR |
| 703.48 Mio. EUR |
| 58.69 Mio. EUR |
| -58.99 Mio. EUR |
| -1.66 EUR |
| 370.51 Mio. EUR |
| 691.14 Mio. EUR |
| 65.36 Mio. EUR |
| 6.29 |
| 73.61% |
| 78.71% |
| - |
| - |
| - |
| - |
| CARIS LIFE |
| 05.04.26 |
|
||||
|